At a glance
- Originator University of Oklahoma Health Sciences Center
- Class Class Ib antiarrhythmics
- Mechanism of Action Potassium channel antagonists; Sodium channel antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Arrhythmias